Regeneron Pharmaceuticals is a strong investment with robust growth potential, fueled by FDA approvals and resilient market ...

Pfizer (NYSE: PFE) stock investors are curious about the valuation and prospects for the healthcare company. *Stock prices ...

The U.S. continues to charge significantly higher prices for prescription drugs compared with similarly wealthy countries.

Aetna is taking legal action against Pfizer, Novartis, Teva Pharmaceuticals and others, saying the list of drugmakers ...

Another $50,000 from tobacco giant Altria last month brings money raised to expand the Republican Party of Kentucky ...

Several large drugmakers, including Pfizer, Bristol Myers Squibb and Sanofi, increased the list prices of their drugs this ...

This is old news, the FDA-spinned student research is late by over a year. Other independent scientists and labs had made this discovery.

Pfizer (NYSE: PFE) is an interesting healthcare company with excellent prospects for cash flow growth. Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day.

The German drugmaker will pay the NIH $791.5 million, while the University of Pennsylvania will get up to $467 million ...

A third dose of COVID-19 vaccine is beneficial among older Medicare beneficiaries, regardless of prior medically attended COVID-19 diagnoses.

Three high-octane income stocks -- sporting an average yield of 7.93% -- can fatten investors' pocketbooks in the new year.

San Diego-based iBio has signed a backloaded agreement with its existing partner AstralBio for a preclinical anti-myostatin ...